References

  • Schappert SM, Burt CW. Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 2001-02. Vital Health Stat 13. 2006;(159):1–66.
  • Dahlhamer J, Lucas J, Zelaya C, Nahin R, Mackey S, DeBar L, Kerns R, Von Korff M, Porter L, Helmick C, et al. Prevalence of chronic pain and high-impact chronic pain among adults—United States, 2016. MMWR Morb Mortal Wkly Rep. 2018;67(36):1001–6. doi:10.15585/mmwr.mm6736a2.
  • Tauben D, Stacey BR. UpToDate. Pharmacologic management of chronic non-cancer pain in adults. Waltham, (MA): UpToDate Inc; [accessed 2021 Aug 30]. https://www.uptodate.com/contents/pharmacologic-management-of-chronic-non-cancer-pain-in-adults.
  • Chou R, Fanciullo GJ, Fine PG, Adler JA, Ballantyne JC, Davies P, Donovan MI, Fishbain DA, Foley KM, Fudin J, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10(2):113–30. doi:10.1016/j.jpain.2008.10.008.
  • Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain. 2006;10(4):287–333. doi:10.1016/j.ejpain.2005.06.009.
  • Zelaya CE, Dahlhamer JM, Lucas JW, Connor EM. Chronic pain and high-impact chronic pain among U.S. adults. NCHS Data Brief. 2019;2020(390):1–8.
  • Lautenbacher S. Experimental approaches in the study of pain in the elderly. Pain Med. 2012;13(Suppl 2):S44–S50. doi:10.1111/j.1526-4637.2012.01326.x.
  • Aufiero M, Stankewicz H, Quazi S, Jacoby J, Stoltzfus J. Pain perception in Latino vs. Caucasian and male vs. female patients: is there really a difference? West J Emerg Med. 2017;18(4):737–42. doi:10.5811/westjem.2017.1.32723.
  • Rahim-Williams B, Riley JL, 3rd, Williams AKK, Fillingim RB. A quantitative review of ethnic group differences in experimental pain response: do biology, psychology, and culture matter? Pain Med. 2012;13(4):522–40. doi:10.1111/j.1526-4637.2012.01336.x.
  • Janakiram C, Chalmers NI, Fontelo P, Huser V, Mitnik GL, Iafolla TJ, Brow AR, Dye BA. Sex and race or ethnicity disparities in opioid prescriptions for dental diagnoses among patients receiving Medicaid. J Am Dent Assoc. 2019;150(10):e135–e144. doi:10.1016/j.adaj.2019.06.016.
  • O'Neill J, Tabish H, Welch V, Petticrew M, Pottie K, Clarke M, Evans T, Pardo Pardo J, Waters E, White H, et al. Applying an equity lens to interventions: using PROGRESS ensures consideration of socially stratifying factors to illuminate inequities in health. J Clin Epidemiol. 2014;67(1):56–64. doi:10.1016/j.jclinepi.2013.08.005.
  • Petkovic J, Trawin J, Dewidar O, Yoganathan M, Tugwell P, Welch V. Sex/gender reporting and analysis in Campbell and Cochrane systematic reviews: a cross-sectional methods study. Syst Rev. 2018;7(1):113. doi:10.1186/s13643-018-0778-6.
  • Evans J, Mwangi N, Burn H, Ramke J. Equity was rarely considered in Cochrane Eyes and Vision systematic reviews and primary studies on cataract. J Clin Epidemiol. 2020;125:57–63. doi:10.1016/j.jclinepi.2020.04.024.
  • Aves T, Kredo T, Welch V, Mursleen S, Ross S, Zani B, Motaze NV, Quinlan L, Mbuagbaw L. Equity issues were not fully addressed in Cochrane human immunodeficiency virus systematic reviews. J Clin Epidemiol. 2017;81:96–100. doi:10.1016/j.jclinepi.2016.09.008.
  • Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8(5):336–41. doi:10.1016/j.ijsu.2010.02.007.
  • Cochrane Methods Equity. PROGRESS-Plus. Ottawa (ON, Canada): The Cochrane Collaboration; [accessed 2021 Aug 9]. https://methods.cochrane.org/equity/projects/evidence-equity/progress-plus.
  • The World Bank. Data, world bank country and lending groups. Washington (DC): The World Bank Group; 2021 [accessed 2021 Feb 25]. https://datahelpdesk.worldbank.org/knowledgebase/articles/906519.
  • Liberati A. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med. 2009;151(4):W65–94. doi:10.7326/0003-4819-151-4-200908180-00136.
  • Chen I, Kurz J, Pasanen M, Faselis C, Panda M, Staton LJ, O’Rorke J, Menon M, Genao I, Wood J, et al. Racial differences in opioid use for chronic nonmalignant pain. J Gen Intern Med. 2005;20(7):593–8. doi:10.1007/s11606-005-0105-5.
  • Hollingshead NA, Ashburn-Nardo L, Stewart JC, Hirsh AT. The pain experience of Hispanic Americans: a critical literature review and conceptual model. J Pain. 2016;17(5):513–28. doi:10.1016/j.jpain.2015.10.022.
  • Ferriss AL. Religion and the quality of life. J Happiness Stud. 2002;3(3):199–215. doi:10.1023/A:1020684404438.
  • Dezutter J, Wachholtz A, Corveleyn J. Prayer and pain: the mediating role of positive re-appraisal. J Behav Med. 2011;34(6):542–9. doi:10.1007/s10865-011-9348-2.
  • Illueca M, Doolittle BR. The use of prayer in the management of pain: a systematic review. J Relig Health. 2020;59(2):681–99. doi:10.1007/s10943-019-00967-8.
  • Kim J-H, Park E-C. Impact of socioeconomic status and subjective social class on overall and health-related quality of life. BMC Public Health. 2015;15(1):783. doi:10.1186/s12889-015-2014-9.
  • Carta MG, Aguglia E, Caraci F, et al. Quality of life and urban/rural living: preliminary results of a community survey in Italy. Clin Pract Epidemiol Ment Health. 2012;8:169–74.
  • Sesso R, Rodrigues-Neto JF, Ferraz MB. Impact of socioeconomic status on the quality of life of ESRD patients. Am J Kidney Dis. 2003;41(1):186–95. doi:10.1053/ajkd.2003.50003.
  • Day MA, Thorn BE. The relationship of demographic and psychosocial variables to pain-related outcomes in a rural chronic pain population. Pain. 2010;151(2):467–74. doi:10.1016/j.pain.2010.08.015.
  • Feldman CH, Dong Y, Katz JN, Donnell-Fink LA, Losina E. Association between socioeconomic status and pain, function and pain catastrophizing at presentation for total knee arthroplasty. BMC Musculoskelet Disord. 2015;16(1):18. doi:10.1186/s12891-015-0475-8.
  • Dionne CE, Von Korff M, Koepsell TD, Deyo RA, Barlow WE, Checkoway H. Formal education and back pain: a review. J Epidemiol Community Health. 2001;55(7):455–68. doi:10.1136/jech.55.7.455.
  • Portenoy RK, Ugarte C, Fuller I, Haas G. Population-based survey of pain in the United States: differences among white, African American, and Hispanic subjects. J Pain. 2004;5(6):317–28. doi:10.1016/j.jpain.2004.05.005.
  • Rafferty AP, Luo H, Egan KL, Bell RA, Gaskins Little NR, Imai S. Rural, suburban, and urban differences in chronic pain and coping among adults in North Carolina: 2018 Behavioral Risk Factor Surveillance System. Prev Chronic Dis. 2021;18:E13.
  • Grol-Prokopczyk H. Sociodemographic disparities in chronic pain, based on 12-year longitudinal data. Pain. 2017;158(2):313–22. doi:10.1097/j.pain.0000000000000762.
  • Rasu RS, Knell ME. Determinants of opioid prescribing for nonmalignant chronic pain in US outpatient settings. Pain Med. 2018;19(3):524–32. doi:10.1093/pm/pnx025.
  • Prostran M, Vujović KS, Vučković S, Medić B, Srebro D, Divac N, Stojanović R, Vujović A, Jovanović L, Jotić A, et al. Pharmacotherapy of pain in the older population: the place of opioids. Front Aging Neurosci. 2016;8:144.
  • Farkouh A, Baumgärtel C, Gottardi R, Hemetsberger M, Czejka M, Kautzky-Willer A. Sex-related differences in drugs with anti-inflammatory properties. J Clin Med. 2021;10(7):1441. doi:10.3390/jcm10071441.
  • Mauvais-Jarvis F, Bairey Merz N, Barnes PJ, Brinton RD, Carrero J-J, DeMeo DL, De Vries GJ, Epperson CN, Govindan R, Klein SL, et al. Sex and gender: modifiers of health, disease, and medicine. Lancet. 2020;396(10250):565–82. doi:10.1016/S0140-6736(20)31561-0.
  • Vlassoff C. Gender differences in determinants and consequences of health and illness. J Health Popul Nutr. 2007;25(1):47–61.
  • Samulowitz A, Gremyr I, Eriksson E, Hensing G. “Brave men” and “emotional women”: a theory-guided literature review on gender bias in health care and gendered norms towards patients with chronic pain. Pain Res Manag. 2018;2018:6358624. doi:10.1155/2018/6358624.
  • Bartley EJ, Fillingim RB. Sex differences in pain: a brief review of clinical and experimental findings. Br J Anaesth. 2013;111(1):52–8. doi:10.1093/bja/aet127.
  • Tong ST, Hochheimer CJ, Brooks EM, Sabo RT, Jiang V, Day T, Rozman JS, Kashiri PL, Krist AH. Chronic opioid prescribing in primary care: factors and perspectives. Ann Fam Med. 2019;17(3):200–6. doi:10.1370/afm.2357.
  • Serdarevic M, Striley CW, Cottler LB. Sex differences in prescription opioid use. Curr Opin Psychiatry. 2017;30(4):238–46. doi:10.1097/YCO.0000000000000337.
  • Paller CJ, Campbell CM, Edwards RR, Dobs AS. Sex-based differences in pain perception and treatment. Pain Med. 2009;10(2):289–99. doi:10.1111/j.1526-4637.2008.00558.x.
  • Morden NE, Munson JC, Colla CH, Skinner JS, Bynum JPW, Zhou W, Meara E. Prescription opioid use among disabled Medicare beneficiaries: intensity, trends, and regional variation. Med Care. 2014;52(9):852–9. doi:10.1097/MLR.0000000000000183.
  • de la Vega R, Groenewald C, Bromberg MH, Beals-Erickson SE, Palermo TM. Chronic pain prevalence and associated factors in adolescents with and without physical disabilities. Dev Med Child Neurol. 2018;60(6):596–601. doi:10.1111/dmcn.13705.
  • Skevington SM. Investigating the relationship between pain and discomfort and quality of life, using the WHOQOL. Pain. 1998;76(3):395–406. doi:10.1016/S0304-3959(98)00072-4.
  • Low Y, Clarke CF, Huh BK. Opioid-induced hyperalgesia: a review of epidemiology, mechanisms and management. Singapore Med J. 2012;53(5):357–60.
  • Cho Y, Lee JK, Kim D-H, Park J-H, Choi M, Kim H-J, Nam M-J, Lee K-U, Han K, Park Y-G, et al. Factors associated with quality of life in patients with depression: a nationwide population-based study. PLoS One. 2019;14(7):e0219455. doi:10.1371/journal.pone.0219455.
  • Seamans MJ, Carey TS, Westreich DJ, Cole SR, Wheeler SB, Alexander GC, Pate V, Brookhart MA. Association of household opioid availability and prescription opioid initiation among household members. JAMA Intern Med. 2018;178(1):102–9. doi:10.1001/jamainternmed.2017.7280.
  • Rigg KK, Murphy JW. Understanding the etiology of prescription opioid abuse: implications for prevention and treatment. Qual Health Res. 2013;23(7):963–75. doi:10.1177/1049732313488837.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.